24 results
8-K
EX-2.1
VYNT
Vyant Bio, Inc.
3 Nov 22
Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary
9:10am
Accounts Receivable
Section 3.23
Bank Accounts, Powers of Attorney
Section 3.24
Title to Personal Properties
Section 3.25
Anti-Corruption Laws
Section 3.26 … .
“Anti-Corruption Laws” shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, and any other similar Laws concerning
424B3
bhcckb2 f4
12 Feb 21
Prospectus supplement
9:43pm
S-4/A
ggs73zlscge 18f0f
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
S-4
uq7d945 upw
16 Oct 20
Registration of securities issued in business combination transactions
11:38am
8-K
EX-2.1
ekkw3oipbi 3hk01r9
24 Aug 20
Cancer Genetics and StemoniX Sign Definitive Agreement to Merge
8:42am
425
EX-2.1
c2qvsgllkvwrzp6
24 Aug 20
Business combination disclosure
8:41am
8-K
EX-2.1
840oudy863v
19 Jul 19
Cancer Genetics, Inc. Announces Strategic Transactions
5:30pm
425
EX-2.1
ig6sgwfkqctwlnl6
21 Sep 18
Business combination disclosure
4:06pm
8-K
EX-2.1
wti9c3jh 47pb
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm